Bionano Genomics, Inc. (BNGO)

USD 2.79

(-7.92%)

Total Debt Summary of Bionano Genomics, Inc.

  • Bionano Genomics, Inc.'s latest annual total debt in 2023 was 87.94 Million USD , up 653.75% from previous year.
  • Bionano Genomics, Inc.'s latest quarterly total debt in 2024 Q2 was 27.57 Million USD , down -35.78% from previous quarter.
  • Bionano Genomics, Inc. reported annual total debt of 11.66 Million USD in 2022, up 9.09% from previous year.
  • Bionano Genomics, Inc. reported annual total debt of 10.69 Million USD in 2021, down -34.48% from previous year.
  • Bionano Genomics, Inc. reported quarterly total debt of 42.92 Million USD for 2024 Q1, down -51.19% from previous quarter.
  • Bionano Genomics, Inc. reported quarterly total debt of 10.14 Million USD for 2023 Q3, down -4.89% from previous quarter.

Annual Total Debt Chart of Bionano Genomics, Inc. (2023 - 2016)

Historical Annual Total Debt of Bionano Genomics, Inc. (2023 - 2016)

Year Total Debt Total Debt Growth
2023 87.94 Million USD 653.75%
2022 11.66 Million USD 9.09%
2021 10.69 Million USD -34.48%
2020 16.32 Million USD -18.47%
2019 20.02 Million USD 121.75%
2018 9.02 Million USD 34.17%
2017 6.72 Million USD 1.46%
2016 6.63 Million USD 0.0%

Peer Total Debt Comparison of Bionano Genomics, Inc.

Name Total Debt Total Debt Difference
bioAffinity Technologies, Inc. 1.57 Million USD -5471.065%
Aspira Women's Health Inc. 2.26 Million USD -3781.156%
Castle Biosciences, Inc. 15.31 Million USD -474.442%
Exact Sciences Corporation 2.55 Billion USD 96.557%
IDEXX Laboratories, Inc. 947.88 Million USD 90.722%
Intelligent Bio Solutions Inc. 871.44 Thousand USD -9992.146%
iSpecimen Inc. 196.24 Thousand USD -44715.128%
Standard BioTools Inc. 98.21 Million USD 10.45%
Inotiv, Inc. 417.64 Million USD 78.942%
Psychemedics Corporation 2.29 Million USD -3727.111%
Prenetics Global Limited 2.36 Million USD -3611.802%
RadNet, Inc. 1.49 Billion USD 94.102%
Star Equity Holdings, Inc. 3.6 Million USD -2336.88%
Neuronetics, Inc. 62.47 Million USD -40.774%
OpGen, Inc. 13.04 Million USD -574.249%
Exagen Inc. 23.72 Million USD -270.756%
CareDx, Inc 34.22 Million USD -156.997%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 94.06 Million USD 6.508%
Guardant Health, Inc. 1.35 Billion USD 93.504%
Biodesix, Inc. 60.69 Million USD -44.909%
BioNexus Gene Lab Corp. 133.39 Thousand USD -65829.757%
Precipio, Inc. 1.11 Million USD -7780.556%
Natera, Inc. 441.99 Million USD 80.102%
Fulgent Genetics, Inc. 14.9 Million USD -489.971%
Sera Prognostics, Inc. 1.85 Million USD -4633.423%
23andMe Holding Co. 76.51 Million USD -14.941%
OPKO Health, Inc. 326.56 Million USD 73.069%
Personalis, Inc. 48.96 Million USD -79.623%
Aclaris Therapeutics, Inc. 426 Thousand USD -20544.836%
Applied DNA Sciences, Inc. 1.23 Million USD -7005.335%
T2 Biosystems, Inc. 49.49 Million USD -77.678%
Neogen Corporation 906.23 Million USD 90.295%
Myriad Genetics, Inc. 145 Million USD 39.347%
ICON Public Limited Company 3.93 Billion USD 97.767%
NeoGenomics, Inc. 611.67 Million USD 85.622%
Star Equity Holdings, Inc. 3.6 Million USD -2336.88%
MDxHealth SA 41.26 Million USD -113.127%
Prenetics Global Limited 2.36 Million USD -3611.802%
Illumina, Inc. 2.26 Billion USD 96.112%
DarioHealth Corp. 29.54 Million USD -197.712%
ENDRA Life Sciences Inc. 394.4 Thousand USD -22198.765%
Medpace Holdings, Inc. 142.12 Million USD 38.119%
Mainz Biomed B.V. 7.42 Million USD -1085.145%
Trinity Biotech plc 67.42 Million USD -30.433%
Sotera Health Company 2.32 Billion USD 96.221%
bioAffinity Technologies, Inc. 1.57 Million USD -5471.065%